Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
In the U.S., more than a dozen kinds of cancer are on the rise among people under 50. The HealthQ team shares the latest guidance on being proactive with your…
In the U.S., more than a dozen kinds of cancer are on the rise among people under 50. The HealthQ team shares the latest guidance on being proactive with your…
At the center of some of healthcare’s most important conversations about patient access, provider burnout, and interoperability is a single pain point: unstructured data. When the HITECH Act pushed healthcare…
The Trump administration finalized a rule that embraces new types of Obamacare coverage, including 30% higher out-of-pocket costs for some plans, and a more novel approach that allows insurers to…
After congressional Republicans let expanded subsidies for Affordable Care Act plans expire at the end of last year, some families have decided the price is too great of a financial…
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
What You Should Know At its keynote in New York City, generative AI pioneer Abridge unveiled the first AI-native clinician intelligence platform built to orchestrate clinical, financial, and evidence-based decisions.…
Independent Medical Examination (IME) documentation exposes a gap in how healthcare systems handle documentation. While most clinical workflows are designed around structured, encounter-based documentation, IME reporting operates outside those assumptions.…
What You Should Know The Louisiana Department of Health (LDH) and biotechnology innovator Phenomune have launched a first-of-its-kind statewide public health initiative providing residents with no-cost, at-home immune insight test…
Pancreatic cancer is still one of the toughest cancers to treat. Once the disease starts growing again after the first round of treatment, the options become limited, and the outlook…